Its Advantage Roche As Indian Patent Office Rejects Valcyte Opposition By Indian Groups
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Swiss drug maker Roche has gained a significant lead against two non-government organizations in its fight over patents of anti-infection drug Valcyte (valgancyclovir) after India's Controller of Patents rejected their pleas for pre-grant opposition